Bortezomib-Induced Bronchiolitis Obliterans Organizing Pneumonia

Introduction. Bortezomib is a proteasome inhibitor indicated for the treatment of multiple myeloma patients. The most frequent side effects are gastrointestinal and neurological. Serious pulmonary complications have been described rarely. Observation. This case involves a 74-year-old man suffering f...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandeix, E., Favard, F., Pichon, N., Delage-Corre, M., Melloni, B., Clavel, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485493/
https://www.ncbi.nlm.nih.gov/pubmed/23133779
http://dx.doi.org/10.1155/2012/430141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485493/
https://www.ncbi.nlm.nih.gov/pubmed/23133779
http://dx.doi.org/10.1155/2012/430141

Ejemplares similares